Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Comparative Study

Review

Research Support, Non-U.S. Gov't

Observational Study

Multicenter Study

Meta-Analysis

Systematic Review

Clinical Trial, Phase II

Clinical Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2025

2024

2020

2018

2017

2016

2015

2014

2013

2012

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Purinergic P2Y Receptor Agonists""[mesh_terms]

18 Results

Searching titles within these results

Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.

Frédéric Chiambaretta, Jean-Jacques Gicquel, Dominique Bremond-Gignac

Expert opinion on drug metabolism & toxicology 2015;10(6):905-13

Full Text

Abstract

Modeling Membrane Protein-Ligand Binding Interactions: The Human Purinergic Platelet Receptor.

D'Artagnan Greene, Wesley M Botello-Smith, Alec Follmer, Li Xiao, Eleftherios Lambros, Ray Luo

The journal of physical chemistry. B 2018;120(48):12293-12304

Free Full Text

Abstract

Diquafosol ophthalmic solution for dry eye treatment.

Takahiro Imanaka, Masatsugu Nakamura, Asuka Sakamoto

Advances in therapy 2013;29(7):579-89

Full Text

Abstract

Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials.

Xinyu Zhao, Song Xia, Youxin Chen

Medicine 2017;96(39):e8174

Free Full Text

Abstract

Synthetic Strategies for Dinucleotides Synthesis.

Lucie Appy, Crystalle Chardet, Suzanne Peyrottes, Béatrice Roy

Molecules (Basel, Switzerland) 2020;24(23):4334

Free Full Text

Abstract

Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye.

Seika Shimazaki-Den, Hiroyuki Iseda, Murat Dogru, Jun Shimazaki

Cornea 2014;32(8):1120-5

Full Text

Abstract

The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study.

N Yokoi, H Kato, S Kinoshita

Eye (London, England) 2017;30(6):857-64

Free Full Text

Abstract

Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.

Kazuo Tsubota, Yuichi Ohashi, Hitoshi Watanabe, Yukihiro Matsumoto

Ophthalmology 2012;119(10):1954-60

Full Text

Abstract

Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes.

Shigeru Kinoshita, Norihiko Yokoi, Hiroaki Kato

American journal of ophthalmology 2014;157(1):85-92.e1

Full Text

Abstract

Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye.

Minako Kaido, Miki Uchino, Takashi Kojima, Murat Dogru, Kazuo Tsubota

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2014;29(6):595-603

Full Text

Abstract

Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye.

Shizuka Koh, Naoyuki Maeda, Chikako Ikeda, Yoshinori Oie, Takeshi Soma, Motokazu Tsujikawa, Hitoshi Watanabe, Kohji Nishida

Acta ophthalmologica 2015;92(8):e671-5

Free Full Text

Abstract

Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.

Ho Sik Hwang, Yoon-Mi Sung, Weon Sun Lee, Eun Chul Kim

Cornea 2015;33(9):935-41

Full Text

Abstract

Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials.

Di Wu, Wang Qi Chen, Ryan Li, Yan Wang

Cornea 2015;34(6):644-50

Full Text

Abstract

Temporal changes in parameters associated with tear film stability after instillation of long-acting diquafosol ophthalmic solution in soft contact lens wearers.

Yuichi Hori, Takashi Suzuki, Takashi Itokawa, Hiroko Iwashita, Yukinobu Okajima, Koji Kakisu

Japanese journal of ophthalmology 2025;69(2):308-315

Free Full Text

Abstract

Efficacy of 3% diquafosol long-acting eye drops in dry eye patients treated for three months.

Tetsuju Sekiryu, Hiroki Maehara, Ryo Mukai, Yusuke Iitaka

Japanese journal of ophthalmology 2024;68(4):338-345

Full Text

Abstract

Results: 1 – 15 / 18

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Purinergic P2Y Receptor Agonists""[mesh_terms]

Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.

Modeling Membrane Protein-Ligand Binding Interactions: The Human Purinergic Platelet Receptor.

Diquafosol ophthalmic solution for dry eye treatment.

Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials.

Synthetic Strategies for Dinucleotides Synthesis.

Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye.

The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study.

Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.

Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes.

Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye.

Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye.

Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.

Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials.

Temporal changes in parameters associated with tear film stability after instillation of long-acting diquafosol ophthalmic solution in soft contact lens wearers.

Efficacy of 3% diquafosol long-acting eye drops in dry eye patients treated for three months.

Results for
""Purinergic P2Y Receptor Agonists""[mesh_terms]